The Cardiotonic Agent Amrinone Does Not Increase Anatomic Infarct Size
- 1 February 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 9 (2) , 225-229
- https://doi.org/10.1097/00005344-198702000-00016
Abstract
An abstract is unavailable. This article is available as a PDF only.This publication has 8 references indexed in Scilit:
- Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining techniquePublished by Elsevier ,2004
- The effect of streptokinase on intramyocardial hemorrhage, infarct size, and the no-reflow phenomenon during coronary reperfusion.Circulation, 1984
- Effects of inotropic and chronotropic stimuli on acute myocardial ischemic injuryThe American Journal of Cardiology, 1984
- Effects of inotropic and chronotropic stimuli on acute myocardial ischemic injury. I. Studies with dobutamine in the anesthetized dog.Circulation, 1982
- Relationship between amrinone plasma concentration and cardiac indexClinical Pharmacology & Therapeutics, 1981
- Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.Circulation, 1980
- Effects of amrinone on experimental acute myocardial ischaemic injuryCardiovascular Research, 1980
- Cardiotonic activity of amrinone--Win 40680 [5-amino-3,4'-bipyridine-6(1H)-one].Circulation Research, 1979